Search

Your search keyword '"Pulsifer B"' showing total 1 results
Start Over Author "Pulsifer B" Topic clinical trials
1 results on '"Pulsifer B"'

1. SMART STOP: A PHASE II CLINICAL TRIAL OF LENALIDOMIDE, TAFASITAMAB, RITUXIMAB, AND ACALABRUTINIB ALONE AND WITH RESPONSE ADAPTED CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED DLBCL.

Author

Westin, J., Strati, P., Chihara, D., Pulsifer, B., Tom, J., Davis, R. E., Lee, H. J., Nair, R., Rodriguez, A., Hagemeister, F., Flowers, C., Nastoupil, L., Feng, L., Green, M., Fayad, L., Iyer, S., Ahmed, S., and Steiner, R.

Subjects
DIFFUSE large B-cell lymphomas, RITUXIMAB, LENALIDOMIDE, CLINICAL trials
Abstract

Patients who achieve less than a CR (Group B or D) will receive LTRA-CHOP for 6 cycles, for a planned 10 cycles of therapy for all patients. B Background: b Diffuse Large B-cell Lymphoma (DLBCL) is cured in ~60% of patients by a chemotherapy-based approach which is largely unchanged for decades. [Extracted from the article]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results